Ronald J. Prentki

2009

In 2009, Ronald J. Prentki earned a total compensation of $577.5K as Former President and Chief Executive Officer at Heron Therapeutics, a 69% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$72,000
Salary$441,346
Stock Awards$56,786
Other$7,350
Total$577,482

Prentki received $441.3K in salary, accounting for 76% of the total pay in 2009.

Prentki also received $72K in non-equity incentive plan, $56.8K in stock awards and $7.4K in other compensation.

Rankings

In 2009, Ronald J. Prentki's compensation ranked 6,355th out of 9,885 executives tracked by ExecPay. In other words, Prentki earned more than 35.7% of executives.

ClassificationRankingPercentile
All
6,355
out of 9,885
36th
Division
Manufacturing
2,318
out of 3,690
37th
Major group
Chemicals And Allied Products
502
out of 866
42nd
Industry group
Drugs
338
out of 638
47th
Industry
Pharmaceutical Preparations
241
out of 446
46th
Source: SEC filing on June 3, 2011.

Prentki's colleagues

We found two more compensation records of executives who worked with Ronald J. Prentki at Heron Therapeutics in 2009.

2009

John Whelan

Heron Therapeutics

Chief Executive Officer

2009

John Barr

Heron Therapeutics

Sr. Vice President, Research and Development

You may also like